Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Spascupreel** is a homeopathic combination remedy manufactured by Biologische Heilmittel Heel GmbH for the treatment of spasms in smooth and striated muscles, including gastrointestinal spasms, intestinal colic, biliary colic, uterine spasms, dysmenorrhea, urinary tract spasms, and muscular spasticity such as myogelosis or fibromyalgia. It contains low-potency dilutions of multiple botanicals and minerals (e.g., Citrullus colocynthis D4, Ammonium bromatum D4, Atropinum sulfuricum D6, Veratrum album D6, Magnesium phosphoricum D6) selected for their traditional antispasmodic, analgesic, and anti-inflammatory effects in homotoxicology. Clinical studies report rapid symptom relief in 70-89% of acute cases within days and 67-80% improvement in chronic spasms within two weeks, with excellent tolerability (no significant side effects or interactions in >95% of patients) compared to conventional spasmolytics like butylscopolamine.[2][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Spascupreel.